Russell Investments Group
HSTO

Russell Investments Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Russell Investments Group’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-79
Closed -$93K – 2994
2018
Q1 		$93K Sell
79
-43
-35% -$47.5K ﹤0.01% 2760
2017
Q4 		$113K Sell
122
-467
-79% -$431K ﹤0.01% 2758
2017
Q3 		$647K Hold
589
– – ﹤0.01% 2348
2017
Q2 		$679K Buy
+589
New +$717K ﹤0.01% 2303

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Russell Investments Group's HSTO Position: Q2 2018 in Review

Russell Investments Group sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 79 shares — an estimated $93K sold.

Russell Investments Group first reported a position in HSTO in Q2 2017 and held it in 4 quarters. The position peaked at $679K in Q2 2017. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • Russell Investments Group reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Russell Investments Group sold 79 Histogen Inc. Common Stock shares in Q2 2018, an estimated $93K.
  • Russell Investments Group first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 4 quarters.
  • Russell Investments Group's Histogen Inc. Common Stock position peaked at $679K in Q2 2017.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on Russell Investments Group's 13F filing for Q2 2018, filed 8 Aug 2018.